Search

everythinglearnresearchcommunity

for

Search:↓

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

Early identification of lupus through skin signs and blood tests is crucial in India.

Lupus can be a rare cause of high calcium levels in the blood.

Areata-like lupus can mimic alopecia areata but is a form of cutaneous lupus erythematosus.

A woman with lupus had right heart failure due to blood clots in her lungs, but treatment improved her condition.

A woman with lupus had blood cell destruction, treated successfully with medication.

Lupus hepatitis can affect male SLE patients and is treatable with specific medications.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Early detection and aggressive treatment of severe lung complications in lupus are crucial to improve survival.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Rash in SLE patients indicates more severe disease.

SLE should be considered in unexplained fevers, even in males.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Early symptoms of SLE include fatigue, joint pain, and sensitivity to sunlight.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.